This is a preview of subscription content, access via your institution
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Get just this article for as long as you need it
Prices may be subject to local taxes which are calculated during checkout
Horwitz EM, Le Blanc K, Dominici M, Mueller I, Slaper-Cortenbach I, Marini FC et al. Clarification of the nomenclature of MSC: The International Society for Cellular Therapy position statement. Cytotherapy 2005; 7: 393–395.
Pittenger M, Mackay A, Beck S, Jaiswal RK, Douglas R, Mosca JD et al. Multilineage potential of adult human mesenchymal stem cells. Science 2000; 284: 143–147.
Di Nicola M, Carlo-Stella C, Magni M, Milanesi M, Longoni PD, Matteucci P et al. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 2002; 99: 3838–3843.
Saccardi R, Mancardi GL, Solari A, Bosi A, Bruzzi P, Di Bartolomeo P et al. Autologous HSCT for severe progressive multiple sclerosis in a multicenter trial: impact on disease activity and quality of life. Blood 2005; 105: 2601–2607.
Aggarwall S, Pittenger MF . Human mesenchymal cells modulate allogenic immune cell response. Blood 2000; 105: 1815–1822.
Bacigalupo A, Valle M, Podesta' M, Pitto A, Zocchi E, De Flora A et al. T-cell suppression mediated by mesenchymal stem cells is deficient in patients with severe aplastic anemia. Exp Hematol 2005; 33: 819–827.
Le Blanc K, Tammik C, Rosendahl K, Zetterberg E, Ringden O . HLA expression and immunological properties of differentiated and undifferentiated mesenchymal stem cells. Exp Hematol 2003; 31: 890–896.
Campioni D, Moretti S, Ferrari L, Punturieri M, Castoldi GL, Lanza F . Immunophenotypic heterogeneity of bone marrow-derived mesenchymal stromal cells from patients with hematologic disorders: correlation with bone marrow microenvironment. Haematologica 2006; 91: 364–368.
Drenou B, Le Friec G, Bernard M, Pangault C, Grosset JM, Lamy T et al. Major histocompatibility complex abnormalities in non-Hodgkin lymphoma. Br J Haematol 2002; 119: 417–424.
Kimura H, Kimura M, Tzou SC, Chen YC, Suzuki K, Rose NR et al. Expression of class II major histocompatibility complex molecules on thyrocytes does not cause spontaneous thyroiditis but mildly increases its severity after immunization. Endocrinology 2005; 146: 1154–1162.
Prockop SE, Palencia S, Ryan CM, Gordon K, Gray D, Petrie HT . Stromal cells provide the matrix for migration of early lymphoid progenitors through the thymic cortex. J Immunol 2002; 169: 4354–4361.
Ruiz C, Reyes-Botella C, Garcia-martinez O, Montes MJ . Modulation of antigenic phenotype by IL-1b, INF-γ and TGF-β on cultured human decidual stromal cells. Biosci Rep 2004; 24: 55–62.
Sotiropoulou PA, Perez SA, Salagianni M, Baxevanis CN, Papamichail M . Characterization of the optimal culture conditions for clinical scale production of human mesenchymal stem cells. Stem Cells 2006; 24: 1409–1410.
Campioni D, Punturieri M, Bardi A, Moretti S, Tammiso E, Lanza F et al. ‘In vitro’ evaluation of bone marrow angiogenesis in myelodysplastic syndromes: a morphological and functional approach. Leuk Res 2004; 28: 9–17.
This work was supported by AIRC Regional Grant and MIUR (Italy).
Rights and permissions
About this article
Cite this article
Lanza, F., Campioni, D., Moretti, S. et al. Aberrant expression of HLA-DR antigen by bone marrow-derived mesenchymal stromal cells from patients affected by acute lymphoproliferative disorders. Leukemia 21, 378–381 (2007). https://doi.org/10.1038/sj.leu.2404492